Table 1.
Characteristics of respondents and distribution of SF-36 scales
| Patient characteristics (N = 200) | |
|---|---|
| Mean (SD) age (years) | 64.7 (±11.1) |
| Mean duration of type 2 diabetes (years) | 7.5 (±1.8) |
| Mean BMI index | 33.0 (±6.0) |
| Mean HbA1c level | 7.5 (±6.7) |
| Treatment type | |
| Nonpharmacological | 14% |
| Only oral | 70% |
| Insulin | 16% |
| Smoking status | |
| Yes | 16% |
| No | 84% |
| Mean blood pressure level (mmHg) | |
| Systolic | 149.3 (±18.3) |
| Diastolic | 86.2 (±11.9) |
| Gender | |
| Female | 61% |
| Male | 39% |
| Awareness of the disease and its complications | |
| Yes | 24% |
| No | 76% |
| Mean (SD) SF-36 scores | |
| Physical functioning | 54.0 (±30.1) |
| Role functioning/physical | 38.1 (±42.2) |
| Role functioning/emotional | 41.6 (±44.8) |
| Energy/fatigue | 43.7 (±18.4) |
| Emotional well being | 61.5 (±20.0) |
| Social functioning | 61.3 (±28.2) |
| Pain | 53.4 (±30.9) |
| General health | 35.3 (±18.1) |
Abbreviations: BMI, body mass index; HbA1c, hemoglobin A1c; SF-36, Rand 36-item short form health survey.